In my opinion, virco®TYPE HIV-1 is a viable alternative to a conventional phenotype that provides me with similar information to a conventional phenotype.
What's New
These modules are presented in an easy to navigate format and begin with a history of the HIV/AIDS epidemic and current epidemiology.
November 2009
Volume 1, Number 3
Presented by Dr. Rafael E. Campo
A 49-year-old African American male, with a history of IDU, unexpectedly presents to the clinic with viremia and declining CD4 cell count after being lost to follow-up for 2.5 years..
Resistance Poll
HIV Resistance Resources
HIV Learning Modules
These modules are presented in an easy to navigate format and begin with a history of the HIV/AIDS epidemic and current epidemiology.
Also included are details of the pathophysiology and the science behind the disease, an overview of the drugs used to treat HIV/AIDS and an extensive section on drug resistance and the use of resistance assays to guide the selection of antiretroviral therapy. More >
Clinical Cases in HIV Resistance
Clinical Cases in HIV Resistance is an ongoing series of patient profiles that illustrate key practice points for clinicians on the use and interpretation of resistance tests in the overall care of HIV-infected patients. More >
July 2009
Volume 1, Number 3
Presented by Dr. Rafael E. Campo
A 49-year-old African American male, with a history of IDU, unexpectedly presents to the clinic with viremia and declining CD4 cell count after being lost to follow-up for 2.5 years.. More >
Virco Product Monograph
These sets of slides were developed to describe the virco®TYPE HIV-1 Report and to assist HIV clinicians in better understanding the analytical processes used to transform an abundance of data into relevant clinical information. More >
Skyscape is pleased to announce the release of the HIV Drug Resource, provided as an educational service by Virco Lab, Inc.
This is a valuable resource for health care providers specializing in the treatment of HIV. It provides a comprehensive listing of 29 FDA approved HIV medications. This resource includes color images of all formulations, two drug identifier listings and full prescribing information.
The HIV Drug Resource is currently being updated. Please check back soon for the latest version.